Zentalis Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • Zentalis Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 71.1M shares, a 0.71% increase year-over-year.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 65.4M shares, a 23.7% increase from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52.9M shares, a 23.8% increase from 2021.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 42.7M shares, a 51.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 65.4M +12.6M +23.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 52.9M +10.2M +23.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 42.7M +14.6M +51.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 28.1M +22.5M +402% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 5.6M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.